Module and Programme Catalogue

Search site

Find information on

2022/23 Taught Postgraduate Module Catalogue

BIOL5280M Integrated Drug Development Plan

20 creditsClass Size: 33

Module manager: Professor Eric Blair
Email: E.Blair@leeds.ac.uk

Taught: Semester 2 (Jan to Jun) View Timetable

Year running 2022/23

Pre-requisite qualifications

A first degree (BSc hons) in a Biological Sciences subject, Bioprocessing or Biochemical Engineering: class 2(i) or above.

Pre-requisites

BIOL5164MBiopharmaceutical Development Pathway

Module replaces

BIOL5265M - Integrated Drug Development Plan

This module is not approved as an Elective

Module summary

This module integrates the pre-clinical aspects of biopharmaceutical product development. Students will create a development plan for a biological medicine to enable its progression to first time in human clinical trials. This will include writing a target product profile, manufacturing, non-clinical and clinical plans; with consideration of the regulatory aspects.

Objectives

The objectives are to:
- Enable the students to develop a deeper understanding of the relationship between, and interdependence, of drug discovery, CMC, non-clinical, clinical and regulatory elements of biologics development.
- Develop an understanding of how to put a biologics medicine development strategy and plan together.
- Develop an appreciation of how to interact with regulatory authorities.
- Provide awareness of the business aspects of biologics development and the relationship with the science.

Learning outcomes
On completion of the module, students should be able to:
- Describe the broad range of activities involved in progression of a biological medicine from research to the clinic.
- Design a biologics development plan to enable a first time in human study.
- Understand the importance of the business aspects of biologics development in the context of the development plan.
- Understand the importance of teamwork and communication skills essential for integrated biologics medicines development.


Syllabus

With students working in teams (Drug Development Teams), the module will cover the following:
- Creating a target product profile for a defined biological molecule.
- Designing the manufacturing plan for the molecule.
- Designing the non-clinical plan for the molecule.
- Designing the clinical plan for the molecule.
- How to review relevant regulatory guidelines and seek regulatory authority advice.
- Understanding the basics of project management including timelines, cost and risk considerations.

Teaching methods

Delivery typeNumberLength hoursStudent hours
Seminar13.003.00
Seminar32.006.00
Tutorial41.004.00
Private study hours187.00
Total Contact hours13.00
Total hours (100hr per 10 credits)200.00

Private study

The students will need to work as teams and provide independent input which needs to be integrated into the team output.

Opportunities for Formative Feedback

Students will meet with an allocated tutor on a regular basis to update on progress made against project timeline and discuss next stages of the project. Progress will be monitored through these sessions.

Methods of assessment


Coursework
Assessment typeNotes% of formal assessment
Group ProjectCSWK1: Written documentation for regulatory panel (4 sides A4, 11pt font) (group)20.00
Oral PresentationCSWK2: Group presentation (4 slides 15 minute presentation). Q&A on presentation & CSWK1. Minutes of meeting (2 slides A4 limit) (group)20.00
ReportCSWK3: Integrated drug development plan report (5000 words)60.00
Total percentage (Assessment Coursework)100.00

Normally resits will be assessed by the same methodology as the first attempt, unless otherwise stated

Reading list

There is no reading list for this module

Last updated: 11/08/2022

Disclaimer

Browse Other Catalogues

Errors, omissions, failed links etc should be notified to the Catalogue Team.PROD

© Copyright Leeds 2019